Derivatives strategy on Torrent Pharmaceuticals by HDFC Securities

Purchase TORRENT PHARMA FEB Potential @ Rs 2,090

Halt loss at Rs 2,040

Goal of Rs 2,250

Rationale:

— The stock value has registered new all time significant with bigger volumes

— Increased tops and bigger bottoms on the everyday and weekly charts

— Stock value is also put higher than all crucial relocating average parameters

— Long build-up is found in the Derivatives Segment

We propose purchasing Torrent Pharma Feb Fut at the latest market value, for the upside focus on of Rs 2,250, retaining halt-loss at 2,040.